Erythropoiesis-stimulating agents and cardiovascular events in patients with myelodysplastic syndrome and multiple myeloma

INTRODUCTION: Erythropoiesis-stimulating agent (ESA) treatment has been associated with an increased risk of venous thromboembolism (VTE) in patients with solid tumors and with an increased risk of cardiovascular events in patients with chronic kidney disease. The ESA-related risk in patients with h...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Clin Epidemiol
Main Authors: Horváth-Puhó, Erzsébet, Suttorp, Marit M, Frederiksen, Henrik, Hoekstra, Tiny, Dekkers, Olaf M, Pedersen, Lars, Cannegieter, Suzanne C, Dekker, Friedo W, Sørensen, Henrik Toft
Format: Artigo
Sprog:Inglês
Udgivet: Dove Medical Press 2018
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6167129/
https://ncbi.nlm.nih.gov/pubmed/30310329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CLEP.S172306
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker